Our objective is to improve population health by addressing the social determinants of health. More broadly, we aim to contribute towards global elimination targets for viral hepatitis, HIV and COVID-19, and contribute to Sustainable Development Goals.
We design and evaluate health interventions to reduce the transmission and impact of blood borne viruses and to improve the health of key populations. We aim to generate ‘real world’ evidence on what works: and inform better public health policy and practice.
Our multidisciplinary team uses mixed methodologies and participatory approaches to develop, trial, and evaluate interventions, assessing their effectiveness and impact.
Our methods and tools include:
- Partnering with affected communities to inform and develop health responses
- Co-design evidence-based interventions
- Training and capacity building
- Designing and planning for implementation at-scale
- Health system strengthening
- Translating evidence into practice
- Program management, measurement, evaluation, and cost-effectiveness
Our group works in partnership with policymakers, practitioners and communities to facilitate the uptake of evidence-based practice, research and innovation into a wide range of health systems and across the community.
Our research has contributed towards innovative local and national programs that have improved health outcomes for communities at risk or living with infectious diseases.
Our group is engaged in multiple ongoing programs and campaigns including:
- The Eliminate Hepatitis C Australia Partnership
- National Hepatitis C Awareness Campaign targeting people with a history of injecting drug use and Aboriginal and Torres Strait Islander communities
- Increasing viral hepatitis HIV and STI testing and treatment among Aboriginal and Torres Strait Islander Peoples in regional settings
- Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs: a cluster randomised controlled trial.
- Preparing for the final phase of elimination in Cairns: An implementation trial of a test-and-treat approach to reach the final 30%.
- The Optimise Study – measuring the health, social and economic impact of COVID-19 on the community
Doctor Alisa Pedrana
Dr Pedrana BBmedSc (hons), PhD (Public Health) is a senior research fellow and public health practitioner, who co-leads the Public Health discipline at Burnet Institute. She holds an adjunct research fellow position at Monash University and Co-lead’s the Health Services Research and Implementation Platform at Monash Partners.
Project
Team
Meet the working group. Together, we are translating research into better health, for all.
